Chemotherapy Followed by Infusion of DMF5 Cells to Treat Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Fludarabine
Related studies linked through entity extraction aliases.
Phase 1/2 Study of Metastatic Renal Cancer Using T-Cells Transduced With a T-Cell Receptor Which Recognizes TRAIL Bound to the DR4 Receptor
- Status
- TERMINATED
- Phase
- PHASE1
Radiation, Chemotherapy, Vaccine and Anti-MART-1 and Anti-gp100 Cells for Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Pilot Study of Unrelated Cord Blood Transplantation
- Status
- TERMINATED
- Phase
- PHASE2
Pilot Study of Reduced Intensity Haematopoietic Stem Cell Transplantation in Patients With Poor Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukaemia (AML) Utilising Conditioning With Fludarabine, Busulphan and Thymoglobulin
- Status
- TERMINATED
- Phase
- PHASE2
Her2 Chimeric Antigen Receptor Expressing T Cells in Advanced Sarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Nonmyeloablative Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL)
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Efficacy of ProHema Modulated Umbilical Cord Blood Units in Subjects With Hematologic Malignancies.
- Status
- COMPLETED
- Phase
- PHASE1
Allogeneic Stem Cell Transplantation (ALLOSCT) in Recessive Dystrophic Epidermolysis Bullosa (RDEB)
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Fludarabine, Bendamustine, and Rituximab in Treating Participants With Lymphoid Cancers Undergoing Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE1
Lenalidomide Following Fludarabine/Rituximab (FR) in Untreated Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2 Study of VELCADE With Fludarabine in Comparison to Rituximab With Fludarabine in Follicular Lymphoma Patients Previously Treated With Rituximab
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Obinutuzumab in Combination With Chemotherapy in Participants With CD20+ B-Cell Follicular Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)
- Status
- COMPLETED
- Phase
- PHASE2
Zevalin With Non Myeloablative Allogeneic Stem Cell Transplantation in Patients With Non Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Autologous and Allogeneic Transplant for Relapsed Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Busulfan and Fludarabine Followed by Post-transplant Cyclophosphamide
- Status
- COMPLETED
- Phase
- PHASE2
Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2